HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+14.9%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$272M
AUM Growth
+$272M
(+4.9%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
27.33%
Holding
177
New
29
Increased
50
Reduced
55
Closed
31
Top Buys
| 1 |
Viridian Therapeutics
VRDN
|
$4.25M |
| 2 |
Advanced Micro Devices
AMD
|
$2.19M |
| 3 |
Celldex Therapeutics
CLDX
|
$2.17M |
| 4 |
Ferguson
FERG
|
$2.15M |
| 5 |
Mineralys Therapeutics
MLYS
|
$2.03M |
Top Sells
| 1 |
Albertsons Companies
ACI
|
$4.15M |
| 2 |
GE Vernova
GEV
|
$3.07M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$3.03M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$2.1M |
| 5 |
Bausch Health
BHC
|
$2.03M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Technology | 22.09% |
| 3 | Industrials | 8.52% |
| 4 | Financials | 6.08% |
| 5 | Consumer Discretionary | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Structure Therapeutics
GPCR
$1.14B
| $1.8M | 0.66% |
86,621
+69,060
| +393% | +$1.43M |
|
|
SNDK
52
Sandisk Corporation Common Stock
SNDK
$7.73B
| $1.8M | 0.66% |
+39,600
| New | +$1.8M |
|
53
Rhythm Pharmaceuticals
RYTM
$6.75B
| $1.77M | 0.65% |
28,068
-6,971
| -20% | -$440K |
|
54
Hewlett Packard
HPE
$29.9B
| $1.76M | 0.65% |
86,200
-47,300
| -35% | -$967K |
|
55
PTC
PTC
$25.4B
| $1.74M | 0.64% |
10,122
+41
| +0.4% | +$7.07K |
|
|
TLN
56
Talen Energy Corporation Common Stock
TLN
$17.3B
| $1.72M | 0.63% |
5,900
-1,800
| -23% | -$523K |
|
57
Spyre Therapeutics
SYRE
$1.02B
| $1.69M | 0.62% |
112,805
+17,646
| +19% | +$264K |
|
58
Entegris
ENTG
$12B
| $1.69M | 0.62% |
+20,900
| New | +$1.69M |
|
59
Cisco
CSCO
$268B
| $1.64M | 0.6% |
23,600
-8,600
| -27% | -$597K |
|
60
Progressive
PGR
$145B
| $1.57M | 0.58% |
5,900
+900
| +18% | +$240K |
|
61
Bank of America
BAC
$371B
| $1.54M | 0.57% |
+32,600
| New | +$1.54M |
|
62
Delta Air Lines
DAL
$40B
| $1.51M | 0.56% |
30,800
| – | – |
|
63
Alkermes
ALKS
$4.95B
| $1.51M | 0.56% |
52,944
-17,818
| -25% | -$510K |
|
64
Liquidia Corp
LQDA
$2.52B
| $1.5M | 0.55% |
120,641
-82,869
| -41% | -$1.03M |
|
65
Apellis Pharmaceuticals
APLS
$3.51B
| $1.5M | 0.55% |
86,663
-22,051
| -20% | -$382K |
|
66
Charles Schwab
SCHW
$175B
| $1.49M | 0.55% |
+16,300
| New | +$1.49M |
|
67
Guardant Health
GH
$8.11B
| $1.47M | 0.54% |
28,265
-23,453
| -45% | -$1.22M |
|
68
Workday
WDAY
$62.3B
| $1.46M | 0.54% |
6,100
+500
| +9% | +$120K |
|
69
Janux Therapeutics
JANX
$1.38B
| $1.44M | 0.53% |
62,436
-12,120
| -16% | -$280K |
|
70
Royal Caribbean
RCL
$96.4B
| $1.44M | 0.53% |
4,600
-4,200
| -48% | -$1.32M |
|
71
CME Group
CME
$97.1B
| $1.43M | 0.53% |
+5,200
| New | +$1.43M |
|
72
Sea Limited
SE
$107B
| $1.43M | 0.53% |
8,941
-1,700
| -16% | -$272K |
|
73
Xenon Pharmaceuticals
XENE
$2.99B
| $1.43M | 0.52% |
45,620
-21,168
| -32% | -$663K |
|
74
RBC Bearings
RBC
$12.1B
| $1.42M | 0.52% |
3,700
+300
| +9% | +$115K |
|
75
TKO Group
TKO
$15.3B
| $1.38M | 0.51% |
7,600
-1,600
| -17% | -$291K |
|